Find clinical trials for Endometrial Cancer in Houston, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Houston, TX, USA:
and Femara (letrozole) can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will al...
Phase 2
Houston, Texas, United States and 1 other location
To learn if chemotherapy given in combination with radiation therapy, followed by maintenance therapy, can help to control endometrial cancer...
Phase 1
Houston, Texas, United States
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Shenandoah, Texas, United States and 65 other locations
To learn if the combination of DKN-01 and pembrolizumab can help to control advanced or recurrent endometrial cancer....
Phase 2
Houston, Texas, United States
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Houston, Texas, United States and 223 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Houston, Texas, United States and 202 other locations
and metformin can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will also be stu...
Phase 2
Houston, Texas, United States and 5 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Houston, Texas, United States and 168 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Houston, Texas, United States and 73 other locations
in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), platinum-re ...
Phase 1
Houston, Texas, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal